Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:01 PM ET 8-K
M&A Deal Tomi Environmental Solutions, Inc. TOMZ

Tomi Environmental Solutions M&A Deal with Carbonium Core, Inc.

TOMI Environmental Solutions and Carbonium Core have mutually agreed to terminate their previously announced merger agreement originally signed on June 28, 2026. The termination follows additional due diligence regarding Carbonium's business operations and financial performance, with neither party required to pay a termination fee.

Counterparty
Carbonium Core, Inc.
5:01 PM ET 8-K
M&A Deal Weave Communications, Inc. WEAV

Weave Communications M&A Deal with Francisco Partners Management, L.P.

Weave Communications received early termination of the HSR Act waiting period for its pending acquisition by affiliates of Francisco Partners. This regulatory milestone satisfies a key closing condition for the merger, which was originally announced on August 18, 2026. The transaction is currently expected to close in the fourth quarter of 2026, subject to stockholder approval.

Counterparty
Francisco Partners Management, L.P.
4:59 PM ET 8-K
M&A Deal Construction Partners, Inc. ROAD

Construction Partners M&A Deal with Roads, Inc. of NWF

Construction Partners, Inc. (CPI) has completed the acquisition of Roads, Inc. of NWF, an asphalt manufacturing and construction business based in Cantonment, Florida. The deal includes a hot-mix asphalt plant north of Pensacola and adds more than 150 employees to CPI's Florida platform, C.W. Roberts Contracting. The acquisition is intended to expand the company's service capabilities and geographic footprint in the Florida Panhandle.

Counterparty
Roads, Inc. of NWF
4:40 PM ET 8-K
Capital Raise Orion180 Insurance Group Inc. OIG

Orion180 Insurance Group Capital Raise of $240M

Orion180 Insurance Group Inc. completed its initial public offering (IPO) of 20,000,000 shares of Class A common stock at a price of $12.00 per share. The offering generated gross proceeds of $240.0 million and coincided with the appointment of five new directors to the company's board.

Value
$240M
4:37 PM ET 8-K
M&A Deal PTC Therapeutics, Inc. PTCT

PTC Therapeutics M&A Deal with Sangamo Therapeutics, Inc.

PTC Therapeutics has completed its acquisition of ST-920 (isaralgagene civaparvovec), a BLA-stage AAV gene therapy for Fabry disease, from Sangamo Therapeutics. The company expects to complete a rolling Biologics License Application (BLA) submission to the FDA for accelerated approval in the fourth quarter of 2026. The acquisition adds a potential one-time treatment for Fabry disease to PTC's rare disorder pipeline.

Counterparty
Sangamo Therapeutics, Inc.
4:35 PM ET 8-K
Capital Raise PennantPark Private Income Fund

PennantPark Private Income Fund Capital Raise of $830K

PennantPark Private Income Fund issued and sold 32,047 common shares for aggregate proceeds of approximately $830,000. The sale was conducted as part of the company's ongoing continuous private offering to accredited investors.

Value
$830K
4:31 PM ET 8-K
M&A Deal Calisa Acquisition Corp ALIS

Calisa Acquisition M&A Deal with Goodvision AI Inc.

Calisa Acquisition Corp entered into a Prepaid Forward Purchase Agreement with Goodvision AI Inc. and Harraden Circle Investments to support its pending business combination. Under the agreement, the purchaser may acquire up to 3,000,000 ordinary shares to minimize redemptions and maximize cash retention upon the closing of the merger.

Counterparty
Goodvision AI Inc.
Term
12 months
4:31 PM ET 8-K
Nasdaq/NYSE Compliance Notice BioCardia, Inc. BCDA

BioCardia Nasdaq/NYSE Compliance Notice

BioCardia has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its common stock closed at or above $1.00 per share for at least 10 consecutive business days. The company had previously received a deficiency notice on August 19, 2026, and Nasdaq has now officially closed the matter. The company's common stock will continue to trade on The Nasdaq Capital Market under the symbol 'BCDA'.

Counterparty
The NASDAQ Stock Market, LLC
4:31 PM ET 8-K
M&A Deal Isabella Bank Corp ISBA

Isabella Bank M&A Deal with Grand River Commerce, Inc.

Isabella Bank Corporation announced that shareholders of Grand River Commerce, Inc. have approved the previously announced merger agreement between the two companies. The transaction, which involves the merger of Grand River into Isabella and their respective bank subsidiaries, is expected to close in the fourth quarter of 2026 subject to regulatory approvals.

Counterparty
Grand River Commerce, Inc.
4:30 PM ET 8-K
Regulatory Approval NewAmsterdam Pharma Co N.V. NAMS

NewAmsterdam Pharma Co Regulatory Approval

NewAmsterdam Pharma and its partner Menarini Group received European Commission marketing authorization for Ubeslo (obicetrapib) and Evlarco (obicetrapib/ezetimibe FDC) for the treatment of hypercholesterolaemia, marking the first regulatory approval for obicetrapib worldwide. The approval triggers milestone payments to NewAmsterdam in the mid-teens of millions of euros under its existing licensing agreement with Menarini. The company remains eligible for up to €833 million in total milestones plus tiered double-digit royalties on net sales in Europe.

Counterparty
Menarini Group
4:30 PM ET 8-K
Nasdaq/NYSE Compliance Notice Linkhome Holdings Inc. LHAI

Linkhome Holdings Nasdaq/NYSE Compliance Notice

Linkhome Holdings Inc. has regained compliance with Nasdaq's minimum bid price requirement after its common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days. The company had previously received a deficiency notice on June 29, 2026, for failing to meet the $1.00 threshold. Nasdaq has officially closed the matter, ensuring the company's continued listing on the Nasdaq Capital Market.

Counterparty
Nasdaq
4:28 PM ET 8-K
Capital Raise Host Digital Inc. HOST

Host Digital Capital Raise of $17.5M

Host Digital Inc. completed an underwritten public offering of 2,187,500 shares of Class A common stock at a price of $8.00 per share, raising approximately $17.5 million in gross proceeds. The company intends to use the net proceeds for data center investments, capital expenditures, and general corporate purposes. Cantor Fitzgerald & Co. acted as the lead book-running manager for the offering.

Value
$17.5M
Counterparty
Cantor Fitzgerald & Co.
4:21 PM ET 8-K
Partnership Visium Technologies, Inc. VISM

Visium Technologies Partnership with PT Visium Compute Indonesia

Visium Technologies executed a non-binding term sheet to form a new Indonesian joint venture vehicle, PT Visium Compute Indonesia (PTVCI), to hold assigned contract-use, offtake, and deployment rights for a device design. Visium's subsidiary will hold a 99% equity interest in the new entity, with the transaction structured as an assignment of rights rather than an acquisition of an operating company. Consideration for the deal is expected to consist of a newly designated series of non-voting convertible preferred stock.

Counterparty
PT Visium Compute Indonesia
4:20 PM ET 8-K
Capital Raise Ares Sports, Media & Entertainment Opportunities LP

Ares Sports, Media & Entertainment Opportunities Capital Raise of $47M

Ares Sports, Media and Entertainment Opportunities LP sold unregistered limited partnership units for approximately $47.0 million as part of its continuous private offering. As of September 21, 2026, the Fund has raised approximately $911 million in aggregate cash consideration through this offering program.

Value
$47M
4:16 PM ET 8-K
M&A Deal Bunker Hill Mining Corp. BHLL

Bunker Hill Mining M&A Deal with Silver47 Exploration Corp.

Bunker Hill Mining Corp. is providing a status update on its pending acquisition of Silver47 Exploration Corp. by filing historical and pro forma financial statements required for the transaction. The filing includes audited financials for Silver47 and Summa Silver Corp. to facilitate the incorporation of the deal into the company's registration statements.

Counterparty
Silver47 Exploration Corp.
4:16 PM ET 8-K
Capacity Expansion Quanome Technologies, Inc. QNME

Quanome Technologies Capacity Expansion: $18.8M Investment

Quanome Technologies entered into a purchase agreement with Compal Electronics to acquire 32 GPU server units for approximately $18.8 million. The company intends to deploy these servers to build out its artificial intelligence computing infrastructure business.

Value
$18.8M
Counterparty
Compal Electronics, Inc.
4:16 PM ET 8-K
Capital Raise Monroe Capital Income Plus Corp

Monroe Capital Income Plus Capital Raise

Monroe Capital Income Plus Corp reported an unregistered sale of equity securities under Item 3.02. As a Business Development Company (BDC), this typically represents the issuance of new shares to investors through a private placement or continuous offering.

4:15 PM ET 8-K
M&A Deal TransDigm Group INC TDG

TransDigm Group Signs $240M M&A Deal with Extant Aerospace / Portfolio of commercial rotorcraft

TransDigm Group's operating unit, Extant Aerospace, has entered into a definitive agreement to acquire a portfolio of commercial rotorcraft, land systems, and business jet products, including a California facility, for approximately $240 million in cash. The acquisition is expected to close during fiscal year 2027, subject to regulatory approvals and customary closing conditions.

Value
$240M
Counterparty
Extant Aerospace (operating unit) / Portfolio of commercial rotorcraft, land systems, and business jet products
4:11 PM ET 8-K
Capital Raise GT Biopharma, Inc. GTBP

GT Biopharma Capital Raise of $7.75M

GT Biopharma amended its securities purchase agreement to increase a private placement of Series M 10% Convertible Preferred Stock and warrants, raising the aggregate purchase price to $7.75 million. The deal includes 'Greenshoe Rights' allowing purchasers to potentially acquire additional preferred stock with an aggregate stated value of up to approximately $34.7 million. The company has committed to filing a registration statement for the resale of the underlying common stock within 30 days of closing.

Value
$7.75M
Counterparty
New Purchaser
4:10 PM ET 8-K
Capital Raise Bbcms Mortgage Trust 2026-M1

Bbcms Mortgage Trust 2026-M1 Capital Raise of $654M

BBCMS Mortgage Trust 2026-M1 entered into agreements to sell $548.3 million in public certificates and $105.4 million in private certificates. The transaction involves the issuance of commercial mortgage pass-through certificates backed by a pool of commercial and multifamily mortgage loans. The closing of the offering is scheduled for September 30, 2026.

Value
$654M
Counterparty
Barclays Capital Inc.
4:06 PM ET 8-K
M&A Deal Lantheus Holdings, Inc. LNTH

Lantheus Holdings M&A Deal with Curium US Holdings LLC

Lantheus Holdings provided a regulatory update on its pending merger with Curium US Holdings LLC, noting that Curium voluntarily withdrew and refiled its HSR Act pre-merger notification to provide the FTC with additional time for review. The new 30-day waiting period is set to expire on October 21, 2026, and the parties still expect to close the transaction in the first half of 2027.

Counterparty
Curium US Holdings LLC
4:06 PM ET 8-K
M&A Deal Insight Molecular Diagnostics Inc. IMDX

Insight Molecular Diagnostics M&A Deal with Chronix Biomedical, Inc.

Insight Molecular Diagnostics (iMDx) entered into Amendment No. 2 to its merger agreement with Chronix, modifying the earnout structure related to the CNI Monitor technology. The amendment establishes that equity holders will receive a 10% royalty on sales until a potential sale of the technology occurs, at which point they will receive a final payment of 10% of the gross sale proceeds.

Counterparty
Chronix Biomedical, Inc.
4:01 PM ET 8-K
Capital Raise Electra Therapeutics, Inc. ETRA

Electra Therapeutics Capital Raise of $350M

Electra Therapeutics closed its initial public offering (IPO) of 23,333,334 shares of common stock at a price of $15.00 per share, generating gross proceeds of approximately $350.0 million. In connection with the closing, the company also filed its amended and restated certificate of incorporation and bylaws.

Value
$350M
4:01 PM ET 8-K
Bankruptcy & Restructuring Sangamo Therapeutics, Inc SGMOQ

Sangamo Therapeutics Bankruptcy & Restructuring

Sangamo Therapeutics completed the sale of its ST-920 (Fabry disease gene therapy) assets to PTC Therapeutics for $111 million in cash plus up to $100 million in contingent milestones. The sale was conducted via a court-supervised auction process as part of Sangamo's ongoing Chapter 11 bankruptcy proceedings. Additionally, the company's common stock is being formally delisted from Nasdaq effective September 27, 2026.

Counterparty
PTC Therapeutics, Inc.
2:32 PM ET 8-K
Capital Raise Barings Private Credit Corp

Barings Private Credit Capital Raise of $22M

Barings Private Credit Corporation sold approximately 1.1 million unregistered shares of common stock for $22.0 million in a private placement. The company is conducting a continuous private offering for up to $4.5 billion, having raised over $3 billion to date.

Value
$22M
11:27 AM ET 8-K
Research Collaboration Deep Fission, Inc. FISN

Deep Fission Research Collaboration with Youngquist Brothers, LLC

Deep Fission has entered into a collaboration with Youngquist Brothers to evaluate and test drilling and borehole-construction methods for its underground nuclear reactor deployment model. The partnership leverages Youngquist's expertise in large-diameter drilling to support Deep Fission's strategy of placing small modular reactors one mile underground. The companies recently completed a successful equipment demonstration in Florida involving a 30-inch prototype reactor canister.

Counterparty
Youngquist Brothers, LLC
9:56 AM ET 8-K
Capital Raise Stone Point Credit Income Fund

Stone Point Credit Income Fund Capital Raise of $12.3M

Stone Point Credit Income Fund issued and sold 498,046.412 common shares to accredited investors for aggregate proceeds of approximately $12.3 million. The shares were sold at a net asset value of $24.6901 per share under private placement exemptions. Since inception, the Fund has received total capital commitments of approximately $1.19 billion, with $776.5 million remaining unfunded.

Value
$12.3M
Counterparty
unnamed accredited investors
9:14 AM ET 8-K
M&A Deal Dick's Sporting Goods, Inc. DKS

Dick's Sporting Goods Signs $2.5B M&A Deal with Foot Locker, Inc.

DICK’S Sporting Goods filed pro forma financial information regarding its completed acquisition of Foot Locker, Inc. for approximately $2.5 billion. The deal consideration consisted of $0.2 billion in cash and 9.6 million shares of DICK’S common stock, alongside a $381.9 million debt exchange offer for Foot Locker's senior notes.

Value
$2.5B
Counterparty
Foot Locker, Inc.
9:06 AM ET 8-K
Product Launch Faraday Future Intelligent Electric Inc. FFAI

Faraday Future Intelligent Electric Product Launch

Faraday Future launched nine new EAI (Embedded AI) device configurations across two robot forms and five models, including the FF All-New Futurist and the FF Master Mini. The company also introduced four Industry Productivity Solutions for sectors such as K-12 education and security, aiming to build a comprehensive 'One-Brain Multi-Form' robotics ecosystem.

9:05 AM ET 8-K
Licensing Deal Recursion Pharmaceuticals, Inc. RXRX

Recursion Pharmaceuticals Licensing Deal with Tempus AI, Inc. Worth $12M

Recursion Pharmaceuticals granted Tempus AI a non-exclusive license to its TxFM RNA sequencing model for use in oncology in exchange for a $12 million license fee. Simultaneously, the parties amended an existing master agreement to extend its term to six years and restructure annual license fees, while Recursion gained access to additional de-identified pathology records.

Value
$12M
Counterparty
Tempus AI, Inc.
Term
2 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.